Skip to main content
Airway Medix S.A. logo

Airway Medix S.A. — Investor Relations & Filings

Ticker · AWM ISIN · PLAIRWY00017 LEI · 259400MDMODKWHZ2EU17 WAR Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2025-05-30 AGM Information
Country PL Poland
Listing WAR AWM

About Airway Medix S.A.

https://airway-medix.com/

Airway Medix S.A. is a company focused on the research, development, and commercialization of innovative, single-use medical devices. Its products are designed for mechanically ventilated patients in intensive care units (ICUs) and anesthesiology departments. The company's portfolio includes the B-Care Oral Care system, an oral hygiene solution with a 360° brush to prevent infections; Cuffix, a device for precise measurement and continuous regulation of endotracheal tube cuff pressure; and the Sweep Air Closed Suction System, which utilizes a unique balloon-based mechanical cleaning mechanism to remove secretions and prevent biofilm formation. These solutions are engineered to improve patient outcomes, prevent complications, and enhance the efficiency of clinical workflows.

Recent filings

Filing Released Lang Actions
zal05_1b._AWM_Projekty_uchwal_na_ZWZ_30.05.25.pdf
AGM Information Classification · 99% confidence The document text is titled "PROJEKTY UCHWAŁ NA ZWYCZAJNE WALNE ZGROMADZENIE AIRWAY MEDIX S.A. ZWOŁANE NA DZIEŃ 27 CZERWCA 2025 ROKU" (Draft Resolutions for the Annual General Meeting of Airway Medix S.A. convened for June 27, 2025). The content consists entirely of proposed resolutions ('Uchwała') for this specific meeting, covering items like electing the Chairman, approving the agenda, approving annual reports (for 2024), covering losses, and granting discharge (absolutorium) to management and supervisory board members. This content directly relates to the proceedings and materials of an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2025-05-30 Polish
zal01_1a._AWM_Ogloszenie_o_zwolaniu_ZWZ_30.05.25.pdf
AGM Information Classification · 100% confidence The document is explicitly titled "OGŁOSZENIE O ZWOŁANIU ZWYCZAJNEGO WALNEGO ZGROMADZENIA" (Announcement of the Convening of the Annual General Meeting). It details the date (27 czerwca 2025 r.), time, location, and a detailed agenda (Porządek obrad) covering the approval of the 2024 financial statements, dividend/loss coverage, and board absolutions. This content directly corresponds to the purpose of an Annual General Meeting (AGM) notice. Therefore, the appropriate classification is AGM-R.
2025-05-30 Polish
Zwołanie Zwyczajnego Walnego Zgromadzenia Airway Medix S.A. - Content (PL)
AGM Information Classification · 98% confidence The document text explicitly announces the convening of a 'Zwyczajnego Walnego Zgromadzenia' (Ordinary General Meeting) on June 27, 2025. It states that the full content of the announcement, along with draft resolutions, is attached. This content directly relates to the scheduling and materials for an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document is short and serves as an announcement/notice regarding the meeting.
2025-05-30 Polish
zal01_AWM_Raport_1Q2025_final.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial report for Airway Medix S.A. covering the period from January 1, 2025, to March 31, 2025. It contains comprehensive financial statements, including the income statement, statement of financial position, and cash flow statement, along with detailed notes. It is not an announcement or a summary, but the full interim report itself, fitting the definition of an Interim / Quarterly Report (IR). Q1 2025
2025-05-30 Polish
Zawarcie umowy dystrybucyjnej - Content (PL)
Regulatory Filings Classification · 95% confidence The document text, written in Polish, discusses a significant event: the signing of a distribution agreement for the sale of products outside the EU. It explicitly links this event to the company's transformation strategy mentioned in the Management Board Report ('Sprawozdaniu Zarządu z działalności'). The content focuses on a major business development (securing a distribution contract) that is expected to generate operating revenue. This type of announcement, detailing a significant business transaction or strategic operational step, best fits the category for major business activities or strategic updates. Since it is not a formal financial report (10-K, IR), an earnings release (ER), or a management discussion/analysis (MDA), and it relates to securing future sales/operations, it aligns most closely with a general business update or strategic development. Given the options, and since it details a major operational/sales agreement, it is best classified as a general Regulatory Filing (RNS) as it is a material event disclosure that doesn't fit the more specific financial or governance codes. However, if we interpret 'distribution agreement' as a significant business transaction impacting future operations, it could potentially relate to 'Capital/Financing Update' (CAP) if it were about funding, or 'Regulatory Filings' (RNS) as a general material event. Given the context of securing sales channels, RNS is the most appropriate fallback for a material business event disclosure not covered elsewhere.
2025-05-15 Polish
Zawarcie umowy dystrybucyjnej
Regulatory Filings Classification · 92% confidence The document text, written in Polish, discusses a significant business development: the signing of a distribution agreement for the sale of products (Cuffix and Oral Care) outside the EU territory. It explicitly frames this as a key step in the company's transformation from a research and development company to a sales company generating operating revenue. This type of announcement, detailing a major commercial contract that impacts future revenue streams and business strategy, aligns best with a general corporate update or a significant business transaction announcement. Since there is no specific category for 'Distribution Agreement Announcement,' and it is not a formal financial report (10-K, IR), earnings release (ER), or management discussion (MDA), it falls under a general regulatory filing or corporate update. Given the context of strategic business transformation and new commercial agreements, it is most appropriately classified as a general Regulatory Filing (RNS) as a catch-all for significant, non-standard announcements, or potentially a Capital/Financing Update (CAP) if the agreement implies significant future capital deployment, but RNS is safer for a general business update. Given the content focuses purely on a sales/distribution contract, RNS is the most suitable fallback.
2025-05-15 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.